Glaukos (GKOS) Depreciation & Amortization (CF) (2014 - 2026)
Glaukos' (GKOS) quarterly Depreciation & Amortization (CF) came in at $11.8 million in Q1 2026, up 43.39% year-on-year from $8.2 million in Q1 2025, and down 3.02% on a QoQ basis from $12.2 million in Q4 2025.
Glaukos (GKOS) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $11.8 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 43.39% year-over-year to $11.8 million in Q1 2026; TTM through Mar 2026 was $41.7 million, a 19.16% increase from a year earlier, with the FY2025 full-year figure at $38.1 million, up 6.85% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $11.8 million, down from $12.2 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for GKOS reached as high as $26.9 million in Q4 2022 and fell as low as $1.4 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $7.4 million across 5 years, with a median of $8.6 million in 2025.
- Across the five-year window, Depreciation & Amortization (CF) plunged 91.49% in 2023 and jumped 328.92% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $26.9 million in 2022, then plunged by 91.49% to $2.3 million in 2023, then soared by 282.16% to $8.7 million in 2024, then surged by 39.18% to $12.2 million in 2025, then fell by 3.02% to $11.8 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $11.8 million in Q1 2026, $12.2 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 11.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.80 Mn |
| Mar 31, 2026 | 11.80 Mn |
| Dec 31, 2025 | 12.16 Mn |
| Dec 31, 2025 | 12.16 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Jun 30, 2025 | 8.57 Mn |
| Jun 30, 2025 | 8.57 Mn |
| Mar 31, 2025 | 8.23 Mn |
| Mar 31, 2025 | 8.23 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 8.91 Mn |
| Mar 31, 2024 | 8.91 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Dec 31, 2023 | 2.29 Mn |